Sunshine Biopharma Inc.
As of Oct 22, 2026, Sunshine Biopharma is in Stage 4, the downtrend phase, now in week 41 (since Dec 31, 2025). It closed at $0.17, 99.1% below its 52-week high and below its 200-day average, which is falling.
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in t… More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is SBFM early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
SBFM among Drug Manufacturers - Specialty & Generic80th of 84 by relative strength
All 84 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | CPIX | Stage 2 · wk 23 | 98 | +6.8% |
| 2 | ETON | Stage 2 · wk 30 | 97 | −10.1% |
| 3 | ANIK | Stage 2 · wk 15 | 96 | +3.5% |
| 4 | IRWD | Stage 3 · wk 3 | 96 | −16.4% |
| 5 | TEVA | Stage 2 · wk 9 | 95 | +3.1% |
| 6 | AMRX | Stage 2 · wk 19 | 95 | +5.9% |
| 7 | KNSA | Stage 2 · wk 73 | 95 | +6.2% |
| 8 | AMLX | Stage 2 · wk 15 | 93 | −6.6% |
| …80 | SBFM | Stage 4 · wk 41 | 3 | −80.9% |
Sunshine Biopharma: quick answers
What stage is Sunshine Biopharma in?
As of Oct 22, 2026, Sunshine Biopharma (SBFM) is in Stage 4, the downtrend phase. It entered Stage 4 on Dec 31, 2025 and is in week 41. What the four stages mean
Is Sunshine Biopharma in an uptrend?
No. Sunshine Biopharma is in a Stage 4 downtrend. It trades 97.1% below its 200-day average, which is falling.
How far is Sunshine Biopharma from its 52-week high?
Sunshine Biopharma closed at $0.17 on Oct 22, 2026, 99.1% below its 52-week high of $19.60. Its 52-week low is $0.17.
How has Sunshine Biopharma performed over the past year?
As of Oct 22, 2026, Sunshine Biopharma is down 99.1% over the past year and down 98.7% so far in 2026.
Which sector and industry is Sunshine Biopharma in?
Sunshine Biopharma is in the Drug Manufacturers - Specialty & Generic industry, part of the Health Care sector.
About this companyHealth Care· Drug Manufacturers - Specialty & Generic
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.